Status:
COMPLETED
Neurocognitive Impairment in Pediatric Patients With Meningoencephalitis and Sepsis-associated Encephalopathy
Lead Sponsor:
University of Rostock
Conditions:
Critical Illness
Brain Injuries
Eligibility:
All Genders
1-17 years
Brief Summary
Neurocognitive impairment is frequently observed in pediatric patients with meningoencephalitis (ME) and sepsis-associated encephalopathy (SAE) which represent two relevant central nervous system (CNS...
Detailed Description
This is a prospective single-center observational study evaluating the incidence and severity of the neurocognitive impairment in pediatric patients with meningoencephalitis (ME) and sepsis-associated...
Eligibility Criteria
Inclusion
- pediatric patients between 1 day and 17 years of age
- admission to hospital with suspected meningoencephalitis or sepsis \<24 hours after admission or time of diagnosis
- admission to hospital for minor surgery (herniotomy, osteosynthesis, adenoidectomy)
Exclusion
- preexisting central nervous system diseases (stroke, hemorrhage, tumor, traumatic brain injury, brain surgery, epilepsy, hydrocephalus)
- preexisting immunosuppression
- participation in another interventional study
- no written informed consent from parents or legal representative
Key Trial Info
Start Date :
August 3 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2022
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04467762
Start Date
August 3 2020
End Date
October 31 2022
Last Update
November 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Rostock
Rostock, Germany, 18059